Dr. Reddy's Laboratories Limited (DRREDDY) — Financial Results | 31 May 2025
Dr. Reddy's Laboratories reported consolidated net profit of ₹67.82 crores for Q4 FY2025, up 32% YoY from ₹51.35 crores in Q4 FY2024, driven by strong revenue growth to ₹2,246.69 crores (+10% YoY). The company posted robust earnings per share of ₹2.67 post-exceptional items, reflecting improved operational performance and margin expansion.
About Dr. Reddy's Laboratories Limited (DRREDDY)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when DRREDDY files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track DRREDDY — Free💡 Ask AI about this filing
📊 More DRREDDY filings
- Announcement — 13 August 2026 Dr. Reddy's Laboratories announced the resignation of CEO Deepak Sapra from the Senior Management Pe...
- Announcement — 7 August 2026 Dr. Reddy's Laboratories announced termination of its distribution agreement with Novartis India eff...
- Announcement — 1 August 2026 Dr. Reddy's Laboratories announced that the U.S. FDA approved its rituximab biosimilar for the U.S. ...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories announced that the US FDA completed a Pre-Approval Inspection and GMP check...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories clarified on July 29, 2026 that a Business Standard news article about Thai...
🔥 Also filed on 31 May 2025
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DRREDDY files new disclosures
Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DRREDDY — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research